期刊文献+

腺相关病毒介导血管内皮生长因子复合无机骨促进骨再生的实验研究 被引量:2

Experimental Study of Guided Bone Regeneration Enhanced by AAV-VEGF Associated with Inorganic Bone Particles
下载PDF
导出
摘要 目的:将血管内皮生长因子(VEGF)与腺相关病毒(AAV)重组,并与无机骨颗粒复合,探讨其对骨组织再生的影响。方法:将24只成年新西兰大白兔随机分为2组,在兔颅骨上建立引导骨再生模型。体外构建承载VEGF基因的腺相关病毒,实验组填充复合有AAV-VEGF的无机骨颗粒,对照组仅填充无机骨颗粒。分别在术后2、4、8周对术区进行组织学观察及形态测量学分析。结果:术后4周及8周时,实验组新生骨量和毛细血管数量均较对照组为多,且骨成熟度更高。免疫组化结果显示实验组VEGF蛋白呈强阳性表达。结论:在引导骨再生时配合AAV-VEGF,较单纯植入无机骨能更快、更有效地促进新生骨形成。 Objective: To evaluate the effects of inorganic bone coated with adeno-associated virus-mediated vascular endothelial growth factor (AAV-VEGF) on new bone formation in a guided bone regeneration model system. Methods: Twenty-four adult male New Zealand white rabbits were randomly divided into 2 groups. A guided bone regeneration model was established on the skull of rabbit. The experimental groups were filled with inorganic bone particles loading with AAV-VEGF, while the control groups were filled with inorganic bone particles only. 2, 4 and 8 weeks after the operations, histological and histomorphometric examination were conducted. Results: The experimental groups appeared to contain more bone and more newly formed blood vessels than control groups at 4 and 8 weeks after implantation. Immunohistochemical analysis showed positive expressions of VEGF protein in the experimental group. Conclusion: Applying AAV-VEGF in GBR could improve the angiogenic and osteogenic effects.
出处 《口腔医学研究》 CAS CSCD 2013年第1期5-8,共4页 Journal of Oral Science Research
基金 国家自然科学基金(编号:61102015) 北京市科技新星计划项目(编号:2006B62) 北京市自然科学基金(编号:3102015)
关键词 血管内皮生长因子 腺相关病毒 引导骨再生 基因治疗 Vascular endothelial growth factor (VEGF) Adeno-associated virus (AAV) Guided bone regeneration (GBR) Gene therapy
  • 相关文献

参考文献5

  • 1董晓宇,井申荣.重组腺相关病毒载体在基因治疗中的应用[J].中国生物制品学杂志,2009,22(7):734-736. 被引量:4
  • 2Yonamine Y,Matsuyama T,Sonomura T, et al.Effectable application of vascular endothelial growth factor to critical sized rat calvaria defects[].Oral Surg Oral Med Oral Pathol Oral Radiol Endod.2010
  • 3J.M.Kanczler,R.O.C.Oreffo.Osteogenesis and angiogene-sis:the potential for engineering bone[].European cells andmaterials.2008
  • 4N.C.Keramarisa,G.M.Calorib,V.S.Nikolaoua,et al.Fracture vascularity and bone healing:A systematic review ofthe role of VEGF[].InjuryIntJCare Injured.2008
  • 5Lundgren AK,Lundgren D,Sennerby L,et al.Augmentationof skull bone using a bioresorbable barrier supported by autol-ogous bone grafts.An intra-individual study in the rabbit[].Clinical Oral Implants Research.1997

二级参考文献30

  • 1Martin KR, Klein RL, Quigley HA. Gene delivery to the eye using adeno-assoeiated viral vectors. Methods, 2002, 28 (2): 267-275.
  • 2Kugler S, Lingor P, Scholl U, et al. Differential transgene expression in brain cells in vivo and in vitro from AAV-2 vectors with small transcriptional control units. Virology, 2003, 311 (1): 89-95.
  • 3Smith A J, Schlichtenbrede FC, Tsehernutter M, et al. AAV-med-iated gene transfer slows photoreceptor loss in the RCS rat model of retinitis pigmentosa. Mol Ther, 2003, 8 ( 11 ): 188-195.
  • 4Carter BJ. Adeno-associated virus and the development of adenoassociated virus vectors: a historical perspective. Mol Ther, 2004, 10 (6): 981-989.
  • 5Fischer AC, Beck SE, Smith CI, et aL Successful transgene expression with serial (loses of aerosolized rAAV2 vectors in rhesus macaques. Mol Ther, 2003, 8 (6): 918-926.
  • 6Sandalon Z, Bruckheimer EM, Lustig KH, et al. Secretion of a TNFR:Fc fusion protein following puhnonary administration of pseudotyped adeno-associated virus vectors. J Virol, 2004, 78 (22): 12355-12365,.
  • 7Flotte TR. Immune responses to recombinant adeno-associatedvirus vectors: putting preclinica| findings into perspective. Hum Gene Ther, 2004, 15 (7): 716-717.
  • 8Hoshijima M, lkeda Y, lwanaga Y, et al. Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery. Nat Med, 2002, 8 (8): 864-871.
  • 9Bartlett JS, Wilcher R, Samulski RJ. Infectious entry pathway of adeno-associated virus and adeno associated virus vectors. J Virol, 2000, 74 (6): 2777- 2785.
  • 10Chao H, Walsh CE. AAV vectors for hemophilia B gene therapy. Mt Sinai Med, 2004, 71 (5): 305-313.

共引文献3

同被引文献15

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部